Carprofen Injection

Land: Australien

Sprog: engelsk

Kilde: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Aktiv bestanddel:

CARPROFEN

Tilgængelig fra:

AVET HEALTH LIMITED

Lægemiddelform:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Sammensætning:

CARPROFEN ANTI-INFLAMMATORY-NONSTEROIDAL Active 50.0 mg/ml

Enheder i pakken:

20 mL

Klasse:

VM - Veterinary Medicine

Terapeutisk område:

ANALGESIC+MUSCULOSKELETAL

Produkt oversigt:

Poison schedule: 4; Withholding period: MEAT WITHHOLDING PERIOD (HORSES): DO NOT USE less than 28 days before slaughter for human consumption.; Host/pest details: CAT: [ANALGESIC, ANTI-INFLAMMATORY AGENT, NON STEROIDAL]; DOG: [ANALGESIC, ANTI-INFLAMMATORY AGENT, NON STEROIDAL]; HORSE: [ANALGESIC, ANTI-INFLAMMATORY AGENT, NON STEROIDAL]

Autorisation status:

Registered

Autorisation dato:

2023-07-01

Indlægsseddel

Label name:
[Wagg & Purr] Carprofen Injection
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
Status:
50 mg/mL Carprofen
Claims:
[Short Claim]
Non-steroidal, anti-inflammatory and analgesic for use in dogs, cats
and horses.
[Long Claim]
Non-steroidal, anti-inflammatory, analgesic for use in dogs, cats and
horses.
For the control of post-operative pain and inflammation following
surgery and
the
alleviation
of
pain
and
inflammation
associated
with
musculoskeletal
disorders in horses.
[Detailed Claim]
[Wagg
&
Purr]
Carprofen
Injection
is
a
non-steroidal,
anti-inflammatory
formulation with analgesic action. It is indicated as an aid in the
alleviation of
pain and inflammation associated with musculoskeletal disorders and
for anti-
inflammatory treatment after surgery in the horse. In the dog and cat,
it is
indicated for the control of post-operative pain and inflammation
following
orthopaedic and soft tissue (including intra-ocular) surgery.
Net Contents:
Status:
20 mL
Directions for
Use:
Product Name:
Carprofen Injection
APVMA Approval No:
90567/129332 RLP APPROVED
Restraints:
Do not administer by intramuscular injection.
Do not exceed the recommended dose or duration of treatment.
Do not administer other NSAID's concurrently or within 24 hours of
each other.
Some NSAID's may be highly bound to plasma proteins and compete with
other
highly bound drugs, which can lead to toxic effects.
Do not use in any animal less than 6 weeks of age, or in aged animals.
Contraindications:
Contraindicated in animals suffering from cardiac, hepatic or renal
disease, or
where there is evidence of a blood dyscrasia or hypersensitivity to
the product.
Avoid use in any dehydrated, hypovolaemic or hypotensive animal as
there is a
potential risk of increased renal toxicity.
Precautions:
Where there is a possibility of gastro-intestinal ulceration or
bleeding, use may
involve additional risk. If such a use cannot be avoided, animals may
require a
reduced dosage and